Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Staples · ·
$17.87
▲ $0.04 (+0.2%)
Market data updated: 09/18 12:59 PM
Fundamentals updated: 09/17/2026
News analyzed: 09/18/2026
Market Cap
$34.32B
Day Range
$17.78 - $18.10
52-Week Range
$14.02 - $20.13
Beta
—
Next Earnings
02.11.2026
KVUE is a stock from the Consumer Defensive sector — Food, beverages, and household products — steady demand even in a recession, since these are essential consumer goods.
-2.4% (1Y)
Strengths: 8/32 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Earnings per share (EPS) growth
Earnings per share (EPS) growth: 40.7%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: $13.20 vs. price $17.87 (-26.2%)
Fair Value
Signal tension
Growth scores strong (68/100), but fair-value analysis scores this stock as relatively expensive (38/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
78/100
Similarity
15
Historical Matches
90/100
Analog Quality
-0.9%
Median 40D Outcome
52/100
Pattern Consistency
🟢 Bullish
53%
+5.0% … +10.6%
🟡 Base
27%
-0.9% … +0.0%
🔴 Bearish
20%
-18.5% … -8.6%
📌 Bottom line: Out of 15 similar historical cases for this stock, 53% (95% CI 30%–75%) saw the stock rise within 20 trading days, with a median gain of +1.0%.
Echo #1 — Momentum Breakout
2 occurrence(s) · 50% historical success
Echo #2 — Oversold Reversal
7 occurrence(s) · 71% historical success
Historical outcome rate is not a probability — it's what happened in this specific historical sample, with a 95% confidence range.
| Horizon | Positive rate (95% CI) | Median | 25th–75th pct | Baseline median |
|---|---|---|---|---|
| 5D | 40% (20%–64%) | -0.2% | -1.4% … +3.2% | +0.1% |
| 10D | 47% (25%–70%) | +0.8% | -1.9% … +3.1% | -0.1% |
| 20D | 53% (30%–75%) | +1.0% | -0.9% … +6.9% | -0.0% |
| 40D | 40% (20%–64%) | -0.9% | -3.6% … +6.8% | +0.5% |
| 60D | 53% (30%–75%) | +4.7% | -10.2% … +11.7% | +0.6% |
Sample size: 15 analogs, each at least 10 trading days apart (no double-counted overlapping events).
What happened after each historical match (20-day return)
| Date | Similarity | Regime | 20D outcome | 60D outcome |
|---|---|---|---|---|
| 2026-05-18 | 78/100 | Consolidation | +7.3% | +11.8% |
| 2024-05-01 | 78/100 | Downtrend | +0.7% | -0.3% |
| 2024-02-21 | 76/100 | Downtrend | +5.8% | +6.7% |
| 2026-06-04 | 75/100 | Downtrend | +15.9% | +11.8% |
| 2026-03-19 | 74/100 | Downtrend | +1.0% | +4.7% |
| 2025-01-02 | 74/100 | ✓ Consolidation | -0.2% | +12.2% |
| 2025-01-23 | 73/100 | Consolidation | +12.4% | +7.3% |
| 2024-06-05 | 73/100 | Downtrend | -3.6% | +15.6% |
| 2025-09-04 | 72/100 | Downtrend | -23.4% | -15.5% |
| 2024-04-17 | 72/100 | Downtrend | +6.6% | -6.0% |
| 2026-04-06 | 71/100 | Downtrend | -0.9% | +11.7% |
| 2025-07-03 | 70/100 | Downtrend | +2.6% | -22.4% |
| 2024-10-17 | 70/100 | Consolidation | +10.1% | -2.8% |
| 2025-06-12 | 68/100 | Downtrend | -1.0% | -14.4% |
| 2025-08-08 | 68/100 | Consolidation | -13.6% | -24.4% |
Every accepted match is compared to today across 6 domains (price structure, momentum, technical, volatility, volume, relative strength) using z-scored feature distances — no single indicator dominates. Matches within 10 trading days of each other count as one event, not independent evidence. Outcome rates use a Wilson confidence interval (never a raw percentage alone), the mean return is winsorized against extreme outliers, and "Analog Quality" separately captures sample size, data completeness, and regime match — distinct from raw similarity. Relative strength is measured against SPY and against XLP (this stock's sector).
Cross-stock analogs — real other companies, not this stock's own history.
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
46
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
68
Quality
47
Value
38
Momentum
13
Risk
40
Sentiment
74
Fundamental
66
Institutional
0
Stocks with a similar DNA right now
SCANNING KVUE...
Recent media coverage of Kenvue has centered on its pending $40 billion acquisition by Kimberly-Clark, with focus on regulatory hurdles, particularly EU and Australian approvals. Analysts highlight potential cost savings of $2.1 billion but also note risks like margin pressures, debt concerns, and uneven sales growth amid litigation fears. The deal’s progress toward closing is tracked alongside Kenvue’s improving profit margins and cash flow, though cautious investor sentiment persists.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Kenvue. News trend score: 74. Reason: 7 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
21
🎯 Conviction (vs. Emotion)
37
Psychology
66
Fundamentals
66
Technical
13
Valuation
38
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The price rise has far outpaced the actual improvement in fundamental data.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price, sentiment, and valuation keep confirming each other upward while the actual fundamentals deteriorate.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price (3M)
-1%
Market Narrative
58
Fundamental Reality
37
Narrative Gap
+21
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
KVUE’s psychology is dominated by anchoring (91), where traders fixate on the 0.5% support level despite modest outperformance relative to peers. The narrative gap (21) and overconfidence (35) suggest investors cling to optimistic expectations, ignoring diverging fundamentals. Herding (41) is muted by underperformance, while euphoria (16) is dampened by negative momentum. The key question: will traders break free from the 0.5% anchor, or will they double down on overvalued expectations?
Updated: 09/09/2026, 06:36 AM
What could change this?
👥 What the crowd believes
"Kimberly-Clark has requested EU permission to complete the $40 billion takeover of Kenvue"
"Documents show the deal entered regulatory review with EU antitrust scrutiny"
"Margin gains offset slow sales growth, while debt remains a risk"
"Deal skepticism and litigation fears still weigh on Kenvue"
📈 13D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 94/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 5/100
🗣️ Why do they disagree?
The methodologies here split sharply between bullish and cautious views on KVUE, reflecting starkly different priorities. Samuel Armstrong Nelson and Morgan Housel’s high scores (96 and 87) suggest this stock aligns with their principles—Nelson sees it as near oversold in its cycle, while Housel views it as a quiet, long-term compounder. Meanwhile, growth-focused investors like Peter Lynch (72) and Charles Mackay (76) see potential, though Lynch’s verdict leans on unfulfilled upside, while Mackay avoids crowd-driven euphoria. On the other end, the lowest scores—from Benjamin Graham (17) and Jesse Livermore (26)—reject it outright, with Graham dismissing it for lacking defensive value and Livermore flagging it as counter-trend. The middle ground, from Howard Marks (50) to Philip Fisher (37), hints at mixed signals: some see a decent business but tempered by high expectations, while others like Bagehot and Schwager warn of liquidity or technical risks. The divide underscores whether the stock’s growth or valuation justifies the risk, with value investors overwhelmingly skeptical while patient, growth-oriented thinkers remain cautiously optimistic.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 94
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 87
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 75
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 73
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 59
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 57
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 56
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 54
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 53
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 50
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 42
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 37
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 37
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 31
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🔴 18
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 5
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 300 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (0 bullish · 10 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
58.1%
Operating Margin
16.0%
Net Margin
9.7%
EBITDA Margin
19.6%
ROE
13.7%
ROA
5.4%
ROIC
—
EPS
$0.77
Cash
$1.06B
Total Debt
$750.00M
Current Ratio
0.96
Debt/Equity
0.07
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 12.8.2026 | $0.210 |
| 13.5.2026 | $0.208 |
| 12.5.2026 | $0.208 |
| 11.2.2026 | $0.208 |
| 10.2.2026 | $0.208 |
| 12.11.2025 | $0.208 |
| 11.11.2025 | $0.208 |
| 13.8.2025 | $0.208 |
| 12.8.2025 | $0.208 |
| 14.5.2025 | $0.205 |
| 13.5.2025 | $0.205 |
| 12.2.2025 | $0.205 |
How is Fair Value calculated? →
Current Price
$17.87
Estimated Fair Value (DCF)
$13.20
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-26.2%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
-0.9%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -0.9% | $1.71B | $1.57B |
| 2 | -0.1% | $1.71B | $1.44B |
| 3 | 0.8% | $1.72B | $1.33B |
| 4 | 1.6% | $1.75B | $1.24B |
| 5 | 2.5% | $1.79B | $1.16B |
Base FCF (last actual year)
$1.72B
Terminal Value
$28.23B
Present Value of Terminal Value
$18.35B
Enterprise Value
$25.08B
Net Debt
$-312.00M
Equity Value
$25.39B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$5.60
Tangible Book Value per Share (Tangible NAV)
-$3.87
Sentiment based on basic keywords (not AI) — 7 positive, 10 neutral, 3 negative out of the last 20 articles.
Yahoo · 18.9.2026
Benzinga · 16.9.2026
ChartMill · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 15.9.2026
Yahoo · 14.9.2026
ChartMill · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Yahoo · 14.9.2026
Barchart · 12.9.2026
Yahoo · 12.9.2026
24/7 Wall St. · 12.9.2026
Yahoo · 12.9.2026
ChartMill · 11.9.2026
ChartMill · 11.9.2026
ChartMill · 10.9.2026
Yahoo · 10.9.2026
Business Wire · 10.9.2026
Kenvue (KVUE) currently has a StockIQ AI score of 46/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
KVUE currently scores 46/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, KVUE's estimated fair value is $13.20, which is 26.2% below the current price of $17.87. This is one valuation model among several signals in the fair-value category, not a price target.
KVUE's technical score is 13/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Earnings per share (EPS) growth: 40.7%; Free cash flow growth: 29.0%; Net income growth: 42.7%.
Based on the real signals StockIQ computed: Estimated fair value: $13.20 vs. price $17.87 (-26.2%); Operating margin is eroding over time; Current ratio: 0.96.
Yes — KVUE has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 2 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Dasgupta Anindya | Exercise of Derivative Securities | 31.7.2026 | 16,418.87 | +16,418.87 | — |
| Dasgupta Anindya | Exercise of Derivative Securities | 31.7.2026 | 16,418.87 | -16,418.87 | — |
| Dasgupta Anindya | Exercise of Derivative Securities | 31.7.2026 | 16,419 | +16,419 | — |
| Dasgupta Anindya | Exercise of Derivative Securities | 31.7.2026 | 32,832 | -16,419 | — |
| ALLISON RICHARD E JR | Grant/Award from Employer | 29.6.2026 | 1,413 | +1,413 | — |
| Smith Jeffrey C | Grant/Award from Employer | 29.6.2026 | 1,413 | +1,413 | — |
| Smith Jeffrey C | Grant/Award from Employer | 29.6.2026 | 27,023 | +1,413 | — |
| ALLISON RICHARD E JR | Grant/Award from Employer | 29.6.2026 | 49,798 | +1,413 | — |
| Howlett Heather | Open Market Sale | 10.6.2026 | 3,700 | -3,700 | $18.11 |
| Howlett Heather | Open Market Sale | 10.6.2026 | 29,288 | -3,700 | $18.11 |
| PAWLUS KATHLEEN M | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| ALLISON RICHARD E JR | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| Mann Erica L | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| Healey Melanie | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| HOLDEN BETSY D | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| Sneed Michael E | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| MERLO LARRY J | Grant/Award from Employer | 21.5.2026 | 16,036 | +16,036 | $17.46 |
| Smith Jeffrey C | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| Hofstetter Sarah | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| PRABHU VASANT M | Grant/Award from Employer | 21.5.2026 | 10,309 | +10,309 | $17.46 |
| HOLDEN BETSY D | Grant/Award from Employer | 21.5.2026 | 36,627 | +10,309 | $17.46 |
| MERLO LARRY J | Grant/Award from Employer | 21.5.2026 | 56,975 | +16,036 | $17.46 |
| PRABHU VASANT M | Grant/Award from Employer | 21.5.2026 | 36,627 | +10,309 | $17.46 |
| Smith Jeffrey C | Grant/Award from Employer | 21.5.2026 | 25,433 | +10,309 | $17.46 |
| Healey Melanie | Grant/Award from Employer | 21.5.2026 | 36,627 | +10,309 | $17.46 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
72,137,384 shares short as of 2026-08-31 · vs. 63,304,672 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
39.3% of trading volume this week was short selling, vs. 51.3% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology